Cytek Biosciences Common Stock share price logo

Cytek Biosciences Common Stock

NASDAQ: CTKB

Small Cap

$4.28

+0.21

(+5.16%)

as on

Cytek Biosciences Common Stock Stock Performance

as on June 25, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $4.11
    $4.39
    downward going graph

    3.97%

    Downside

    2.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.09
    $6.18
    downward going graph

    27.80%

    Downside

    44.39%

    Upside

    downward going graph

Cytek Biosciences Common Stock share price movements today

Previous Close
$4.07
Open
$4.11
Volume
1.6M
Day's Low - High
$4.11 - $4.39
52 Week Low - High
$3.09 - $6.18

Cytek Biosciences Common Stock Historical Returns

1 Month Return
+ 6.73 %
3 Month Return
-6.96 %
1 Year Return
+ 28.53 %
3 Year Return
-46.7 %
5 Year Return
0 %

Cytek Biosciences Common Stock Stock Fundamentals & Key Indicators

Check Cytek Biosciences Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$525.6M

EPS (TTM)

-0.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.73%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-36.3M

Revenue (TTM)

204.2M

Profit Margin

-36.25%

Return On Equity TTM

-20.93%

Cytek Biosciences Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytek Biosciences Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$525.6MNANA-36.25%NA
BUY$118.8B19.27%35.8413.21%1.13%
BUY$50.1B-13.43%46.517.39%NA
BUY$103.2B-35.86%21.6213.20%3.58%
BUY$67.8B0.82%19.0817.29%NA

Stock Returns calculator for Cytek Biosciences Common Stock Stock including INR - Dollar returns

The Cytek Biosciences Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cytek Biosciences Common Stock investment value today

Current value as on today

₹1,41,572

Returns

₹41,572

(+41.57%)

Returns from Cytek Biosciences Common Stock Stock

₹28,529 (+28.53%)

Dollar Impact

₹13,043 (+13.04%)

Analyst Recommendation on Cytek Biosciences Common Stock Stock

Based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Cytek Biosciences Common Stock. Average target price of $5.69

Cytek Biosciences Common Stock Share Price Target

Get share price movements and forecasts by analysts on Cytek Biosciences Common Stock.

What analysts predicted

24.78%UPSIDE

Target Price

$5.69

Current Price

$4.28

Analyzed by

12 Analysts

Target

$5.69

Cytek Biosciences Common Stock target price $5.69, a slight upside of 24.78% compared to current price of $4.28. According to 12 analysts rating.

Indian Investors' Interest in Cytek Biosciences Common Stock Stock

Search interest for Cytek Biosciences Common Stock Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:56% versus previous 30 day period

Cytek Biosciences Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
58
44
46
51
57
41
45
52
62
44
Gross Profit
33
23
25
29
33
20
23
27
32
21
Operating Income
0
-10
-8
-4
2
-14
-10
-9
-5
-18
EBITDA
6
-6
-4
3
-2
-8
-3
-4
0
-14
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
2
2
2
2
2
2
2
3
3
2
Income Before Tax
4
-8
-7
0
10
-11
-6
-7
-4
-17
Income Tax Expense
-1
-2
3
0
0
0
-1
-2
40
1
Net Income
5
-6
-10
0
9
-11
-5
-5
-44
-18
Net Profit Margin
9.45%
-13.75%
-22.38%
1.83%
16.78%
-27.50%
-12.24%
-10.48%
-70.93%
-42.75%

Cytek Biosciences Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
57
92
127
164
193
200
201
Gross Profit
28
51
79
100
109
111
104
Operating Income
-17
13
9
-1
-27
-20
-40
EBITDA
-15
15
8
9
-4
4
-17
Interest Expense
0
0
1
2
2
5
0
Depreciation
0
0
1
5
8
10
11
Income Before Tax
-16
14
5
1
-15
-5
-29
Income Tax Expense
0
-4
2
-1
-3
0
36
Net Income
-16
19
3
2
-12
-6
-66
Net Profit Margin
-29.07%
20.91%
2.35%
1.57%
-6.29%
-3.00%
-33.02%

Cytek Biosciences Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-6
-10
0
9
-11
-5
-5
-44
-18
Operating Cash Flow
3
6
13
1
0
0
-3
0
-2
Investing Cash Flow
-5
2
-15
-63
9
-16
18
-1
-27
Financing Cash Flow
1
-1
-12
-3
-11
-2
1
-1
3
Change in Cash
1
8
-15
-63
-3
-19
17
-2
-25

Cytek Biosciences Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
19
3
2
-12
-6
-66
Operating Cash Flow
15
4
-12
5
25
-4
Investing Cash Flow
-1
-20
-55
-93
-82
10
Financing Cash Flow
122
213
5
-41
-15
-13
Change in Cash
135
198
-65
-131
-68
-7

Global Institutional Holdings in Cytek Biosciences Common Stock

Funds
Holdings
Vanguard Capital Management, LLC
3.69%
Geode Capital Management, LLC
2.19%
Northern Trust Corp
0.78%
New York State Common Retirement Fund
1.64%
Boston Partners Global Investors, Inc
4.49%

Insights on Cytek Biosciences Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CTKB stock has moved up by 13.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CTKB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -44.07M → -18.86M (in $), with an average increase of 133.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Cytek Biosciences, Inc. Common Stock has experienced a drawdown of -46.7%, however Stryker Corporation resisted the overall trend and outperformed by 45.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 62.14M → 44.13M (in $), with an average decrease of 29.0% per quarter

About Cytek Biosciences Common Stock

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
OrganisationCytek Biosciences Common Stock
Headquarters47215 Lakeview Blvd, Fremont, CA, United States, 94538-6407
IndustryMedical Devices
CEODr. Wenbin Jiang Ph.D.
E-voting on sharesClick here to vote

Key Management of Cytek Biosciences Common Stock

Name

Title

Dr. Wenbin Jiang Ph.D.

President, CEO & Chairman of the Board

Mr. William D. McCombe

Chief Financial Officer

Dr. Ming Yan Ph.D.

CTO & Director

Ms. Valerie T. Barnett J.D.

Chief Legal Officer & Corporate Secretary

Mr. Paul D. Goodson

Head of Investor Relations

Mr. Patrik Sebastian Jeanmonod

Head of Corporate Development Analytics

FAQs

What is Cytek Biosciences Common Stock share price today?

Cytek Biosciences Common Stock share price today is $4.28 as on at the close of the market. Cytek Biosciences Common Stock share today touched a day high of $4.39 and a low of $4.11.

What is the 52 week high and 52 week low for Cytek Biosciences Common Stock share?

Cytek Biosciences Common Stock share touched a 52 week high of $6.18 on and a 52 week low of $3.09 on . Cytek Biosciences Common Stock stock price today i.e. is closed at $4.28,which is 30.74% down from its 52 week high and 38.51% up from its 52 week low.

What is Cytek Biosciences Common Stock's market capitalisation today?

Cytek Biosciences Common Stock market capitalisation is $0.00T as on .

How to invest in Cytek Biosciences Common Stock Stock (CTKB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytek Biosciences Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytek Biosciences Common Stock Shares that will get you 0.3505 shares as per Cytek Biosciences Common Stock share price of $4.28 per share as on June 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Cytek Biosciences Common Stock Stock (CTKB) from India?

Indian investors can start investing in Cytek Biosciences Common Stock (CTKB) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Cytek Biosciences Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytek Biosciences Common Stock share’s latest price of $4.28 as on June 25, 2026 at 8:45 am IST, you will get 2.3364 shares of Cytek Biosciences Common Stock. Learn more about fractional shares .